Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5513-5523
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5513
Table 3 Base case results
StrategyCost (I$)QALYsICER (I$)Unadjusted LYs
Average-risk population
No screening5015.6725-22.1245
Lugol’s iodine screening66515.7158Weakly dominated22.1989
HRME screening69615.71841180822.2032
High-risk population
No screening129713.6188-18.8274
Lugol’s iodine screening244914.7408102720.6889
HRME screening291114.7973817320.7764